ArticleIDCases2026
Severe kodsi grade IV esophageal candidiasis in an apparently immunocompetent patient without oral thrush: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Candida esophagitis is the most common fungal infection of the esophagus and typically occurs in patients with impaired immunity or other recognized predisposing conditions. Severe disease in apparently immunocompetent individuals without oral candidiasis is rare and may delay diagnosis. Case presentation: A 35-year-old previously healthy man presented with a two-month history of progressive odynophagia, cough, and unintentional weight loss. He had no history of diabetes mellitus, malignancy, chronic kidney or liver disease, corticosteroid use, broad-spectrum antibiotic exposure, proton pump inhibitor therapy, smoking, or alcohol consumption. Human immunodeficiency virus serology was nonreactive, fasting blood glucose and glycated hemoglobin were within normal limits, and examination revealed no oral candidiasis. Upper gastrointestinal endoscopy demonstrated extensive confluent whitish plaques with marked mucosal friability and luminal narrowing, consistent with severe Kodsi grade IV esophageal candidiasis on endoscopic appearance. Histopathological confirmation, fungal culture, species identification, and immunological investigations were not performed because of mucosal friability, financial limitations, and restricted diagnostic resources. The patient was treated with intravenous fluconazole and experienced rapid clinical improvement, with sustained symptomatic recovery at two-week follow-up. Conclusion: This case demonstrates that severe Kodsi grade IV Candida esophagitis may occur in apparently immunocompetent individuals without oral candidiasis or identifiable risk factors. Clinicians should maintain a high index of suspicion for esophageal candidiasis in patients with persistent odynophagia despite the absence of classical predisposing conditions. Prompt endoscopic evaluation and early antifungal therapy are critical for timely diagnosis and prevention of complications, particularly in resource-limited settings where histopathological confirmation may not be feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.